Entity · moving across domains

FDA

FDA — U.S. Food and Drug Administration. The U.S. regulator that approves drugs, medical devices, and food safety.

As of 11 Nov 2026Last evidence 11 Nov 2026

What is happening now

  • FDA approves cosibelimab-ipdl for metastatic or locally advanced cutaneous squamous cell carcinoma

    Reported event · first reported 7 Nov 2026 to 9 Nov 2026 · 2 claims · best-carried claim: 1 separate publisher

  • Novocure’s device for treating brain metastases rejected by FDA

    Reported claim · first reported 10 Nov 2026 · 1 claim · best-carried claim: 1 separate publisher

  • FDA grants accelerated approval to pirtobrutinib for chronic lymphocytic leukemia and small lymphocytic lymphoma

    Reported claim · first reported 9 Nov 2026 · 1 claim · best-carried claim: 1 separate publisher

  • FDA Orders New Vision Loss Warning for Ozempic, Wegovy, Mounjaro and Zepbound

    Reported claim · first reported 9 Nov 2026 · 1 claim · best-carried claim: 2 separate publishers

  • STAT+: FDA approves novel Bayer drug to reduce recurrence of stroke

    Reported claim · first reported 9 Nov 2026 · 1 claim · best-carried claim: 2 separate publishers

All 11 events and claims involving FDA

What changed

  • Attention Rising: 177 mentions on 11 Nov 2026, against 124 on 21 Oct 2026 (+43%).
  • State Last recorded change: coverage state went from steady to rising on 5 Nov 2026 (1 change recorded since 5 Nov 2026).
  • Claims 1 claim first reported since 10 Nov 2026.

How well we know this

3,442 documents · 277 publishers · 36% say something specific about it · last evidence 11 Nov 2026

  • Gap: 36% of mentions say something specific about it; the rest only name it

In this snapshot’s daily coverage:

Reported alongside FDA

Names most often reported alongside it; bigger circles and heavier lines mean more shared documents. A dashed circle has no page of its own yet.

Northern Marian…United StatesAIUs Food
  • Drug Administration · 1,313 shared documents · no page of its own yet
  • Clinical Trial · 514 shared documents · no page of its own yet
  • Northern Mariana Islands · 500 shared documents
  • U.s. Food · 457 shared documents · no page of its own yet
  • United States · 445 shared documents
  • Clinical Trials · 432 shared documents · no page of its own yet
  • AI · 430 shared documents
  • Fda-Approved · 311 shared documents · no page of its own yet
  • Us Food · 277 shared documents
  • Public Health · 273 shared documents · no page of its own yet

Story momentum

Rising

The word compares 177 mentions on 11 Nov 2026 with 124 on 21 Oct 2026 (+43%); a change of less than 8% either way reads Steady.

Daily mentions +69% from 27 Sept 2026 to 11 Nov 2026, between 13 and 177 a day

How often tracked coverage mentions FDA, day by day.

Market price, cited

Not priced yet

No open prediction market prices a question materially about FDA yet. Ask about FDA

No market price on file: no prediction market prices a question about this name yet

Coverage volume and market price are separate measures.

On the desk: Health & Bio Desk

For developers

This page is also an object: GET https://sigb.ai/api/v1/node/e/1ccaf7a7b68e32af55cbc6a4 returns the same record as sb.node.v1. Or call the get_entity MCP tool at https://sigb.ai/api/mcp with name fda.

{
  "name": "fda",
  "label": "FDA",
  "asOf": "2026-11-11",
  "mentions": 177,
  "domains": 29,
  "node": {
    "id": "sb:e/1ccaf7a7b68e32af55cbc6a4",
    "schema": "sb.node.v1",
    "rest": "https://sigb.ai/api/v1/node/e/1ccaf7a7b68e32af55cbc6a4",
    "knowledgeCutoff": "2026-11-11T18:49:29.902137+00:00",
    "snapshot": "this deploy's committed data files (commit not exposed in this runtime)"
  },
  "coverageTrend": "rising",
  "history": {
    "since": "2026-11-05T13:11:02.767988+00:00",
    "changes": 1
  },
  "whereFrom": {
    "level": "counts",
    "label": "177 mentions across 29 domains",
    "children": [
      {
        "level": "reports",
        "label": "6 reports drawn on this page, each with its link",
        "children": {
          "count": 6,
          "unfold": "expand=+1"
        }
      },
      {
        "level": "domains",
        "label": "29 coverage domains",
        "children": {
          "count": 18,
          "unfold": "expand=+1"
        }
      },
      {
        "level": "not shown",
        "label": "The other 171 mentions",
        "edge": "counted daily from tracked coverage; single mentions are not listed one by one"
      }
    ]
  }
}

The figures on this page, as data. The tool returns the full entity record.

Events involving FDA

Most-reported first, then newest. Registered events come from the event record; reported events are groups of claims about one occurrence. Claims are grouped when they were first reported within 2 days of each other and either name at least 2 of the same people, places or things besides this one, or share at least 25% of their wording. Each claim keeps its own record.

  • FDA approves cosibelimab-ipdl for metastatic or locally advanced cutaneous squamous cell carcinoma

    Reported event · first reported 7 Nov 2026 to 9 Nov 2026 · 2 claims · best-carried claim: 1 separate publisher

    Show the 2 individual claims
    • FDA approves selpercatinib for locally advanced or metastatic RET fusion-positive solid tumors · single source · first reported 9 Nov 2026 · 1 separate publisher
    • FDA approves cosibelimab-ipdl for metastatic or locally advanced cutaneous squamous cell carcinoma · single source · first reported 7 Nov 2026 · 1 separate publisher

  • Novocure’s device for treating brain metastases rejected by FDA

    Reported claim · first reported 10 Nov 2026 · 1 claim · best-carried claim: 1 separate publisher

    single source

  • FDA grants accelerated approval to pirtobrutinib for chronic lymphocytic leukemia and small lymphocytic lymphoma

    Reported claim · first reported 9 Nov 2026 · 1 claim · best-carried claim: 1 separate publisher

    single source

  • FDA Orders New Vision Loss Warning for Ozempic, Wegovy, Mounjaro and Zepbound

    Reported claim · first reported 9 Nov 2026 · 1 claim · best-carried claim: 2 separate publishers

    could not check

  • STAT+: FDA approves novel Bayer drug to reduce recurrence of stroke

    Reported claim · first reported 9 Nov 2026 · 1 claim · best-carried claim: 2 separate publishers

    reported by two

  • FDA orders class-wide GLP-1 label update to include potential risk for rare eye disease

    Reported claim · first reported 9 Nov 2026 · 1 claim · best-carried claim: 7 separate publishers

    corroborated

  • Samsung Bioepis Puts Keytruda Biosimilar Into FDA Review With Full Phase 3 Lung Cancer Trial Data

    Reported claim · first reported 7 Nov 2026 · 1 claim · best-carried claim: 3 separate publishers

    corroborated

  • FDA approves amivantamab-vmjw with carboplatin and pemetrexed for non-small cell lung cancer with EGFR exon 19 deletions or L858R mutations

    Reported claim · first reported 7 Nov 2026 · 1 claim · best-carried claim: 1 separate publisher

    single source

  • Lilly and Hims & Hers expand access to FDA-approved Lilly medicines

    Reported claim · first reported 6 Nov 2026 · 1 claim · best-carried claim: 2 separate publishers

    could not check

  • PulseAI Receives U.S. FDA 510(k) Clearance of AI-Powered Arrhythmia Analysis Model for Wearables

    Reported claim · first reported 5 Nov 2026 · 1 claim · best-carried claim: 1 separate publisher

    single source

  • HUTCHMED (HCM) Secures Second FDA Orphan Drug Designation for Sovleplenib Targeting Autoimmune Hemolytic Anaemia

    Reported claim · first reported 5 Nov 2026 · 1 claim · best-carried claim: 2 separate publishers

    could not check

Walk the record from FDA

Open where it comes from, follow a claim or a related name, and use the trail to come back. Every step says what it is, how it stands and when. Machines read the same record.

FDA

Entity.

Evidence
3,442 documents · 277 separate publishers · a mention shows the name is in use, not that any claim about it is true
Standing
A name from our starting list; its record is kept up to date automatically from coverage
Time
first seen 6 Apr 2026, last seen 11 Nov 2026
Measured
36% of mentions say something specific about it; the rest only name it
As of
11 Nov 2026
22 links from here

Who it moves with: the 10 names are in the map above.

What is claimed about it (12)

  • Corroborated: Reported by three or more sources that did not copy each other.
  • Reported by two: Reported by two sources that did not copy each other.
  • Single source: Reported by one source so far.
  • Could not check: We could not count this claim's sources, so we do not say how well it is supported.

Situations it is named in (0)

none on file at this cutoff

For machines: this record as JSON

Watch this

What the coverage says

Recent reporting that names FDA, newest first. Open any row to follow it to the original article.

Evidence tiers: primary source = an official public record · attributed = a named outlet, receipt linked · lead = observed, not yet receipted.

Markets materially about FDA

Markets whose question is about FDA or names it as a party. Each row says how the market relates to FDA and why. Prices are the market’s own, cited with the venue.

What it connects to

Related records.

Recorded history

  • 5 Nov 2026

    coverage state changed: steady to rising

    Previous state held since 4 Nov 2026

1 change recorded since 5 Nov 2026, newest first.

Ask about FDAWatch FDA

Story momentum counts mentions in tracked coverage. Prices are the market’s own, cited with the venue. Informational only, not advice. As of 11 Nov 2026.